Johannes Oldenburg (J Oldenburg)

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 14

Top Topics

Health Promotion

Replacement Therapy

Top Venues

Haemophilia : the official journal of the World Federation of Hemophilia

This page only lists publications with an associated author ORCID identifier.

Publications

Erik Berntorp, Petra LeBeau, Margaret V Ragni, Munira Borhany, Yasmina L Abajas, Michael D Tarantino, Katharina Holstein, Stacy E Croteau, Riana Liesner, Cristina Tarango, Manuela Carvalho, Catherine E McGuinn, Eva Funding, Christine L Kempton, Christoph Bidlingmaier, Alice Cohen, Johannes Oldenburg, Susan Kearney, Christine Knoll, Philip Kuriakose, Suchitra Acharya, Ulrike M Reiss, Roshni Daniel Kulkarni, Michelle Witkop, Stefan Lethagen, Rebecca Krouse, Amy D Shapiro, Jan Astermark
Quality of life in a large multinational haemophilia B cohort (The B-Natural study) - Unmet needs remain. Haemophilia : the official journal of the World Federation of Hemophilia 28 (3) (2022)
Andreas Tiede, Hendrik Leise, Silvia Horneff, Johannes Oldenburg, Susan Halimeh, Christine Heller, Christoph Königs, Katharina Holstein, Christian Pfrepper
Safety of intramuscular COVID-19 vaccination in patients with haemophilia. Haemophilia : the official journal of the World Federation of Hemophilia 28 (5) (2022)
Beatrice Nolan, Johnny N Mahlangu, Ingrid Pabinger, Guy Aaron Young, Barbara A Konkle, Chris Barnes, Keiji Nogami, Elena Santagostino, K John Pasi, Liane Khoo, Bent Winding, Huixing Yuan, Joachim Fruebis, Dan Rudin, Johannes Oldenburg
Recombinant factor VIII Fc fusion protein for the treatment of severe haemophilia A: Final results from the ASPIRE extension study. Haemophilia : the official journal of the World Federation of Hemophilia 26 (3) (2020)
Amy D Shapiro, Margaret V Ragni, Munira Borhany, Yasmina L Abajas, Michael D Tarantino, Katharina Holstein, Stacy E Croteau, Riana Liesner, Cristina Tarango, Manuela Carvalho, Catherine E McGuinn, Eva Funding, Christine L Kempton, Christoph Bidlingmaier, Alice Cohen, Johannes Oldenburg, Susan Kearney, Christine Knoll, Philip Kuriakose, Suchitra Acharya, Ulrike M Reiss, Roshni Daniel Kulkarni, Michelle L Witkop, Stefan Lethagen, Sharyne Donfield, Petra LeBeau, Erik Berntorp, Jan Astermark
Natural history study of factor IX deficiency with focus on treatment and complications (B-Natural). Haemophilia : the official journal of the World Federation of Hemophilia 27 (1) (2020)
Andreas Tiede, Santiago Bonanad, Amparo Santamaria, Georg Goldmann, Mariana Canaro, Antonio Palomero, Luis J G Frade, Juan Eduardo Megías-Vericat, Maria Fernanda Martinez Garcia, Faustino Garcia Candel, Victor Jimenez Yuste, Monika Sparber-Sauer, Susan Halimeh, Daniela Adolf, Martin Hukauf, Jan Reichmann, Johannes Oldenburg
Quality of electronic treatment records and adherence to prophylaxis in haemophilia and von Willebrand disease: Systematic assessments from an electronic diary. Haemophilia : the official journal of the World Federation of Hemophilia 26 (6) (2020)
K John Pasi, Kathelijn Fischer, Margaret V Ragni, Roshni Daniel Kulkarni, Margareth C Ozelo, Johnny N Mahlangu, Amy D Shapiro, Stephanie P'Ng, Hervé Chambost, Beatrice Nolan, Carolyn Bennett, Tadashi Matsushita, Bent Winding, Joachim Fruebis, Huixing Yuan, Dan Rudin, Johannes Oldenburg
Long-term safety and sustained efficacy for up to 5 years of treatment with recombinant factor IX Fc fusion protein in subjects with haemophilia B: Results from the B-YOND extension study. Haemophilia : the official journal of the World Federation of Hemophilia 26 (6) (2020)
Rebecca Kruse-Jarres, Johannes Oldenburg, Elena Santagostino, Midori Shima, Christine L Kempton, Craig M Kessler, Michaela Lehle, Sammy Chebon, Nives Selak Bienz, Elina Asikanius, Johnny N Mahlangu
Bleeding and safety outcomes in persons with haemophilia A without inhibitors: Results from a prospective non-interventional study in a real-world setting. Haemophilia : the official journal of the World Federation of Hemophilia 25 (2) (2019)
Manuel D Carcao, Carmen Escuriola-Ettingshausen, Elena Santagostino, Johannes Oldenburg, Ri Liesner, Beatrice Nolan, Angelika Bátorová, Saturnino Haya, Guy Aaron Young, null null
The changing face of immune tolerance induction in haemophilia A with the advent of emicizumab. Haemophilia : the official journal of the World Federation of Hemophilia 25 (4) (2019)
Elena Santagostino, Savita Rangarajan, Johannes Oldenburg, Roser Peiró-Jordan, Víctor Jiménez-Yuste
Rapid and sustained immune tolerance to inhibitors induced by a plasma-derived, VWF-containing FVIII concentrate. Haemophilia : the official journal of the World Federation of Hemophilia 25 (2) (2019)
Johnny N Mahlangu, Johannes Oldenburg, Michael U Callaghan, Midori Shima, Elena Santagostino, Maggie Moore, Michael Recht, Claudia Garcia, Renchi Yang, Michaela Lehle, Harrison Macharia, Elina Asikanius, Gallia G Levy, Rebecca Kruse-Jarres
Bleeding events and safety outcomes in persons with haemophilia A with inhibitors: A prospective, multi-centre, non-interventional study. Haemophilia : the official journal of the World Federation of Hemophilia 24 (6) (2018)
S Elayaperumal, N A Fouzia, A Biswas, S C Nair, A Viswabandya, B George, A Abraham, Johannes Oldenburg, E S Edison, Alok Srivastava
Type-3 von Willebrand disease in India-Clinical spectrum and molecular profile. Haemophilia : the official journal of the World Federation of Hemophilia 24 (6) (2018)
Steven R Lentz, Dragana Janic, Kaan Kavakli, Predrag Miljic, Johannes Oldenburg, Margareth Castro Ozelo, Elena Santagostino, Takashi Suzuki, Silva Zupancic Šalek, Lars Korsholm, Irina Matytsina, Andreas Tiede
Long-term safety and efficacy of turoctocog alfa in prophylaxis and treatment of bleeding episodes in severe haemophilia A: Final results from the guardian 2 extension trial. Haemophilia : the official journal of the World Federation of Hemophilia 24 (6) (2018)
Kate Khair, M G Mazzucconi, R Parra, E Santagostino, D A Tsakiris, C Hermans, Johannes Oldenburg, G Spotts, K Steinitz-Trost, A Gringeri
Pattern of bleeding in a large prospective cohort of haemophilia A patients: A three-year follow-up of the AHEAD (Advate in HaEmophilia A outcome Database) study. Haemophilia : the official journal of the World Federation of Hemophilia 24 (1) (2017)
Johannes Oldenburg, Roshni Daniel Kulkarni, Alok Srivastava, J N Mahlangu, V S Blanchette, E Tsao, B Winding, J Dumont, N Jain
Improved joint health in subjects with severe haemophilia A treated prophylactically with recombinant factor VIII Fc fusion protein. Haemophilia : the official journal of the World Federation of Hemophilia 24 (1) (2017)